ENTITY
Astellas Pharma

Astellas Pharma (4503 JP)

228
Analysis
Health Care • Japan
Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fields of Urology, Immunology including Transplantation and Infectious Diseases, Oncology, Neuroscience and DM Complications and Metabolic Diseases. With over 17,000 global employees, Astellas researches, develops, manufactures, and promotes its prescription drugs through subsidiaries in the US, Europe, and Asia
more
bullish•Quantitative Analysis
•16 Aug 2020 07:37

Asia Short Interest Weekly: AliHealth, Meituan, SunnyOptical, WuXi Apptec, Canon, Lasertec, Seegene

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
498 Views
Share
bullish•Quantitative Analysis
•25 Jul 2020 10:01

Asia Short Interest Weekly: JD, Netease, CSPC, Alibaba, Meituan, Tencent, Fanuc, Mitsubishi, Toshiba

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
508 Views
Share
bullish•Takeda Pharmaceutical
•29 Apr 2020 14:02

Takeda Pharma Divests Yet Another Non-Core Asset to Pay-Off Debt and Focus on Core Areas

On 24th April, Takeda Pharmaceutical announced that it has entered into an agreement to sell off a portfolio of select non-core over the counter...

Share
bullish•Quantitative Analysis
•28 Apr 2020 16:36

More Covering on Consumer Staples and Discretionary

The short notional in the market for the data released 28 April is US$33.44bn (down by US$62mm excluding FX movements and ETFs) with the largest...

Logo
478 Views
Share
bullish•Johnson & Johnson
•02 Apr 2020 18:57

J&J’s Purchase of Takeda’s Surgical Patch Subject to EU Investigation; Expect a Deal Anyways

In May 2019, Japan’s biggest drugmaker, Takeda announced the sale of its surgical patch product, TachoSil to Johnson & Johnson’s subsidiary...

Share
x